Several additional Tau phosphorylation sites observed in AD, S396/404, S217, S235, S400/T403/S404, and T181, were hyperphosphorylated when treated with Aβ42 oligomers (Supplementary Fig. 2V–Z). Here, MAPT is linked to Alzheimer disease.